Novel insights into protein misfolding diseases revealed by ion mobility-mass spectrometry

Mass Spectrometry Reviews

Volumn 32, Issue 3, 2013, Pages 169-187

  Williams, Danielle M ^a   Pukala, Tara L ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

amyloid fibrils; ion mobility mass spectrometry; protein aggregation; protein conformation; protein misfolding diseases

Indexed keywords

AMYLOID FIBRIL; ION MOBILITY-MASS SPECTROMETRY; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN MISFOLDING;

AGGLOMERATION; GLYCOPROTEINS; MASS SPECTROMETRY; NEURODEGENERATIVE DISEASES; OLIGOMERIZATION; OLIGOMERS;

PROTEINS;

AMYLOID;

ANIMAL; CHEMISTRY; EQUIPMENT; EQUIPMENT DESIGN; HUMAN; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEOSTASIS DEFICIENCY; REVIEW;

AMYLOID; ANIMALS; EQUIPMENT DESIGN; HUMANS; MASS SPECTROMETRY; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEOSTASIS DEFICIENCIES;

EID: 84876298403     PISSN: 02777037     EISSN: 10982787     Source Type: Journal    
DOI: 10.1002/mas.21358     Document Type: Review

References (125)

1. Anfinsen CB, Redfield RR, Choate WL, Page J, Carroll WR,. 1954. Studies on the gross structure, cross-linkages, and terminal sequences in ribonuclease. J Biol Chem 207: 201-210.
2. Antony T, Hoyer W, Cherny D, Heim G, Jovin TM, Subramaniam V,. 2003. Cellular polyamines promote the aggregation of α-synuclein. J Biol Chem 278: 3235-3240.
3. Badman ER, Myung S, Clemmer DE,. 2005. Evidence for unfolding and refolding of gas-phase cytochrome c ions in a paul trap. J Am Soc Mass Spectrom 16: 1493-1497.
4. Barghorn S, Nimmrich V, Striebinger A, Krantz C, Keller P, Janson B, Bahr M, Schmidt M, Bitner RS, Harlan J, Barlow E, Ebert U, Hillen H,. 2005. Globular amyloid beta-peptide oligomer-A homogenous and stable neuropathological protein in Alzheimer's disease. J Neurochem 95: 834-847.
5. Barnett D, Ells B, Guevremont R, Purves R,. 1999. Separation of leucine and isoleucine by electrospray ionization-high field asymmetric waveform ion mobility spectrometry-mass spectrometry. J Am Soc Mass Spectrom 10: 1279-1284.
6. Baumketner A, Bernstein SL, Wyttenbach T, Bitan G, Teplow DB, Bowers MT, Shea JE,. 2006a. Amyloid beta-protein monomer structure: A computational and experimental study. Protein Sci 15: 420-428.
7. Barrera NP, Robinson CV,. 2011. Advances in the mass spectrometry of membrane proteins: from individual proteins to intact complexes. Annu Rev Biochem 80: 247-247.
8. Baumketner A, Bernstein SL, Wyttenbach T, Lazo ND, Teplow DB, Bowers MT, Shea JE,. 2006b. Structure of the 21-30 fragment of amyloid beta-protein. Protein Sci 15: 1239-1247.
9. Benesch JL, Aquilina JA, Ruotolo BT, Sobott F, Robinson CV,. 2006. Tandem mass spectrometry reveals the quaternary organization of macromolecular assemblies. Chem Biol 13: 597-605.
10. Benesch JL, Ruotolo BT, Simmons DA, Robinson CV,. 2007. Protein complexes in the gas phase: Technology for structural genomics and proteomics. Chem Rev 107: 3544-3567.
11. Bernstein SL, Liu D, Wyttenbach T, Bowers MT, Lee JC, Gray HB, Winkler JR,. 2004. Alpha-synuclein: Stable compact and extended monomeric structures and ph dependence of dimer formation. J Am Soc Mass Spectrom 15: 1435-1443.
12. Bernstein SL, Wyttenbach T, Baumketner A, Shea JE, Bitan G, Teplow DB, Bowers MT,. 2005. Amyloid beta-protein: Monomer structure and early aggregation states of abeta42 and its pro19 alloform. J Am Chem Soc 127: 2075-2084.
13. Bernstein SL, Dupuis NF, Lazo ND, Wyttenbach T, Condron MM, Bitan G, Teplow DB, Shea JE, Ruotolo BT, Robinson CV, Bowers MT,. 2009. Amyloid-beta protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. Nat Chem 1: 326-331.
14. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM,. 2005. Intraneuronal aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45: 675-688.
15. Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB,. 2003a. Amyloid beta protein (abeta) assembly: Abeta 40 and abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci USA 100: 330-335.
16. Bitan G, Tarus B, Vollers SS, Lashuel HA, Condron MM, Straub JE, Teplow DB,. 2003b. A molecular switch in amyloid assembly: Met35 and amyloid β-protein oligomerization. J Am Chem Soc 125: 15359-15365.
17. Bohrer BC, Merenbloom SI, Koeniger SL, Hilderbrand AE, Clemmer DE,. 2008. Biomolecule analysis by ion mobility spectrometry. Ann Rev Anal Chem 1: 293-327.
18. Borysik AJH, Read P, Little DR, Bateman RH, Radford SE, Ashcroft AE,. 2004. Separation of beta(2)-microglobulin conformers by high-field asymmetric waveform ion mobility spectrometry (FAIMS) coupled to electrospray ionisation mass spectrometry. Rapid Commun Mass Spectrom 18: 2229-2234.
19. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi MH,. 2007. Forecasting the global burden of Alzheimer's disease. Alzheimer's and Dementia 3 (3): 186-191.
20. Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A, Yates J, Cotman C, Glabe C,. 1992. Assembly and aggregation properties of synthetic Alzheimers a4/beta amyloid peptide analogs. J Biol Chem 267: 546-554.
21. Bush MF, Hall Z, Giles K, Hoyes J, Robinson CV, Ruotolo BT,. 2010. Collision cross sections of proteins and their complexes: A calibration framework and database for gas-phase structural biology. Anal Chem 82: 9557-9565.
22. Cech NB, Enke CG,. 2001. Practical implications of some recent studies in electrospray ionization fundamentals. Mass Spectrom Rev 20: 362-387.
23. Chen XY, Westphall MS, Smith LM,. 2003. Mass spectrometric analysis of DNA mixtures: Instrumental effects responsible for decreased sensitivity with increasing mass. Anal Chem 75: 5944-5952.
24. Cheng IH, Scearce-Levie K, Legleiter J, Palop JJ, Gerstein H, Bien-Ly N, Puoliväli J, Lesné S, Ashe KH, Muchowski PJ, Mucke L,. 2007. Accelerating amyloid-β fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J Biol Chem 282: 23818-23828.
25. Chiti F, Dobson CM,. 2006. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75: 333-366.
26. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH,. 2005. Natural oligomers of the amyloid-[beta] protein specifically disrupt cognitive function. Nat Neurosci 8: 79-84.
27. Clemmer DE, Hudgins RR, Jarrold MF,. 1995. Naked protein conformations-Cytochrome-c in the gas-phase. J Am Chem Soc 117: 10141-10142.
28. Ding H, Wong PT, Lee EL, Gafni A, Steel DG,. 2009. Determination of the oligomer size of amyloidogenic protein beta-amyloid(1-40) by single-molecule spectroscopy. Biophys J 97: 912-921.
29. Dole M, Mack LL, Hines RL, Mobley RC, Ferguson LD, Alice MB,. 1968. Molecular beams of macroions. J Chem Phys 49: 2240-2249.
30. Domon B, Aebersold R,. 2006. Mass spectrometry and protein analysis. Science 312: 212-217.
31. Dukes KD, Rodenberg CF, Lammi RK,. 2008. Monitoring the earliest amyloid-beta oligomers via quantized photobleaching of dye-labeled peptides. Anal Biochem 382: 29-34.
32. Dupuis NF, Wu C, Shea JE, Bowers MT,. 2009. Human islet amyloid polypeptide monomers form ordered beta-hairpins: A possible direct amyloidogenic precursor. J Am Chem Soc 131: 18283-18292.
33. Dupuis NF, Wu C, Shea J-E, Bowers MT,. 2011. The amyloid formation mechanism in human iapp: Dimers have β-strand monomer-monomer interfaces. J Am Chem Soc 133: 7240-7243.
34. Ecroyd H, Carver JA,. 2008. Unraveling the mysteries of protein folding and misfolding. IUBMB Life 60: 769-774.
35. Ekeowa UI, Freeke J, Miranda E, Gooptu B, Bush MF, Perez J, Teckman J, Robinson CV, Lomas DA,. 2010. Defining the mechanism of polymerization in the serpinopathies. Proc Natl Acad Sci USA 107: 17146-17151.
36. Faull PA, Korkeila KE, Kalapothakis JM, Gray A, McCullough BJ, Barran PE,. 2009. Gas-phase metalloprotein complexes interrogated by ion mobility-mass spectrometry. Int J Mass Spectrom 283: 140-148.
37. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM,. 1989. Electrospray ionization for mass-spectrometry of large biomolecules. Science 246: 64-71.
38. Freeke J, Robinson CV, Ruotolo BT,. 2010. Residual counter ions can stabilise a large protein complex in the gas phase. Int J Mass Spectrom 298: 91-98.
39. Gejyo F, Odani S, Yamada T, Honma N, Saito H, Suzuki Y, Nakagawa Y, Kobayashi H, Maruyama Y, Hirasawa Y, Suzuki M, Arakawa M,. 1986. Beta2-microglobulin: A new form of amyloid protein associated with chronic hemodialysis. Kidney Int 30: 385-390.
40. Gessel MM, Wu C, Li H, Bitan G, Shea JE, Bowers MT,. 2012. Aβ(39-42) modulates Aβ oligomerization but not fibril formation. Biochemistry 51: 108-117.
41. Giles K, Pringle SD, Worthington KR, Little D, Wildgoose JL, Bateman RH,. 2004. Applications of a travelling wave-based radio-frequencyonly stacked ring ion guide. Rapid Commun Mass Spectrom 18: 2401-2414.
42. Gouras GK, Almeida CG, Takahashi RH,. 2005. Intraneuronal aβ accumulation and origin of plaques in Alzheimer's disease. Neurobiol Aging 26: 1235-1244.
43. Grabenauer M, Bernstein SL, Lee JC, Wyttenbach T, Dupuis NF, Gray HB, Winkler JR, Bowers MT,. 2008. Spermine binding to Parkinson's protein alpha-synuclein and its disease-related A30P and A53T mutants. J Phys Chem B 112: 11147-11154.
44. Grabenauer M, Wyttenbach T, Sanghera N, Slade SE, Pinheiro TJ, Scrivens JH, Bowers MT,. 2010. Conformational stability of Syrian hamster prion protein PrP(90-231). J Am Chem Soc 132: 8816-8818.
45. Grundke-Iqbal I, Iqbal K, George L, Tung YC, Kim KS, Wisniewski HM,. 1989. Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. Proc Natl Acad Sci USA 86: 2853-2857.
46. Hartings MR, Kinnear BS, Jarrold MF,. 2003. The energy landscape of unsolvated peptides: The role of context in the stability of alanine/glycine helices. J Am Chem Soc 125: 3941-3947.
47. Hernandez H, Dziembowski A, Taverner T, Seraphin B, Robinson CV,. 2006. Subunit architecture of multimeric complexes isolated directly from cells. EMBO Rep 7: 605-610.
48. Hilton GR, Thalassinos K, Grabenauer M, Sanghera N, Slade SE, Wyttenbach T, Robinson PJ, Pinheiro TJ, Bowers MT, Scrivens JH,. 2010. Structural analysis of prion proteins by means of drift cell and traveling wave ion mobility mass spectrometry. J Am Soc Mass Spectrom 21: 845-854.
49. Hoaglund CS, Valentine SJ, Sporleder CR, Reilly JP, Clemmer DE,. 1998. Three-dimensional ion mobility/TOFMS analysis of electrosprayed biomolecules. Anal Chem 70: 2236-2242.
50. Hou L, Kang I, Marchant RE, Zagorski MG,. 2002. Methionine 35 oxidation reduces fibril assembly of the amyloid aβ-(1-42) peptide of Alzheimer's disease. J Biol Chem 277: 40173-40176.
51. Hudgins RR, Mao Y, Ratner MA, Jarrold MF,. 1999. Conformations of Gly(n)H+ and Ala(n)H+ peptides in the gas phase. Biophys J 76: 1591-1597.
52. Hull RL, Westermark GT, Westermark P, Kahn SE,. 2004. Islet amyloid: A critical entity in the pathogenesis of type 2 diabetes. J Clin Endorcrinol Metab 89: 3629-3643.
53. Hyung SJ, Robinson CV, Ruotolo BT,. 2009. Gas-phase unfolding and disassembly reveals stability differences in ligand-bound multiprotein complexes. Chem Biol 16: 382-390.
54. Jan A, Gokce O, Luthi-Carter R, Lashuel HA,. 2008. The ratio of monomeric to aggregated forms of aβ40 and aβ42 is an important determinant of amyloid-β aggregation, fibrillogenesis, and toxicity. J Biol Chem 283: 28176-28189.
55. Jenner P,. 2007. Oxidative stress and Parkinson's disease. Handb Clin Neurol 83: 507-520.
56. João M, Saraiva M,. 1995. Transthyretin mutations in health and disease. Hum Mutat 5: 191-196.
57. Kaddis CS, Lomeli SH, Yin S, Berhane B, Apostol MI, Kickhoefer VA, Rome LH, Loo JA,. 2007. Sizing large proteins and protein complexes by electrospray ionization mass spectrometry and ion mobility. J Am Soc Mass Spectrom 18: 1206-1216.
58. Karas M, Hillenkamp F,. 1988. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem 60: 2299-2301.
59. Kim J, Onstead L, Randle S, Price R, Smithson L, Zwizinski C, Dickson DW, Golde T, McGowan E,. 2007. Aβ40 inhibits amyloid deposition in vivo. J Neurosci 27: 627-633.
60. Klein WL, Stine WB Jr, Teplow DB,. 2004. Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer's disease. Neurobiol Aging 25: 569-580.
61. Kloniecki M, Jablonowska A, Poznanski J, Langridge J, Hughes C, Campuzano I, Giles K, Dadlez M,. 2011. Ion mobility separation coupled with ms detects two structural states of Alzheimer's disease abeta 1-40 peptide oligomers. J Mol Biol 407: 110-124.
62. Last AM, Robinson CV,. 1999. Protein folding and interactions revealed by mass spectrometry. Curr Opin Chem Biol 3: 564-570.
63. Leary JA, Schenauer MR, Stefanescu R, Andaya A, Ruotolo BT, Robinson CV, Thalassinos K, Scrivens JH, Sokabe M, Hershey JW,. 2009. Methodology for measuring conformation of solvent-disrupted protein subunits using t-wave ion mobility ms: An investigation into eukaryotic initiation factors. J Am Soc Mass Spectrom 20: 1699-1706.
64. Lesné S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH,. 2006. A specific amyloid-[beta] protein assembly in the brain impairs memory. Nature 440: 352-357.
65. Levy G,. 2007. The relationship of Parkinson disease with aging. Arch Neurol 64: 1242-1246.
66. Lin Z, Madan D, Rye HS,. 2008. Groel stimulates protein folding through forced unfolding. Nat Struct Mol Biol 15: 303-311.
67. Liu YQ, Ho LH, Carver JA, Pukala TL,. 2011. Ion mobility mass spectrometry studies of the inhibition of alpha synuclein amyloid fibril formation by (-)-epigallocatechin-3-gallate. Aust J Chem 64: 36-40.
68. Loo JA,. 1997. Studying noncovalent protein complexes by electrospray ionization mass spectrometry. Mass Spectrom Rev 16: 1-23.
69. Loo JA,. 2000. Electrospray ionization mass spectrometry: A technology for studying noncovalent macromolecular complexes. Int J Mass Spectrom 200: 175-186.
70. Loo JA, Berhane B, Kaddis CS, Wooding KM, Xie Y, Kaufman SL, Chernushevich IV,. 2005. Electrospray ionization mass spectrometry and ion mobility analysis of the 20s proteasome complex. J Am Soc Mass Spectrom 16: 998-1008.
71. Mack E,. 1925. Average cross-sectional areas of molecules by gaseous diffusion methods. J Am Chem Soc 47: 2468-2482.
72. Martins Branco D, Arduino DM, Esteves AR, Silva DFF, Cardoso SM, Oliveira C,. 2010. Cross-talk between mitochondria and proteasome in Parkinson's disease pathogenesis. Front Aging Neurosci 2, 17: 1-10.
73. Mesleh MF, Hunter JM, Shvartsburg AA, Schatz GC, Jarrold MF,. 1996. Structural information from ion mobility measurements: Effects of the long-range potential. J Phys Chem 100: 16082-16086.
74. Morales R, Duran-Aniotz CA, Soto C,. 2012. Role of prion protein oligomers in the pathogenesis of transmissible spongiform encephalopathies. In:, Rahimi F, Bitan G, editors. Non-fibrillar amyloidogenic protein assemblies-Common cytotoxins underlying degenerative diseases. Netherlands: Springer. pp 319-335.
75. Morrison LD, Cao XC, Kish SJ,. 1998. Ornithine decarboxylase in human brain: Influence of aging, regional distribution, and Alzheimer's disease. J Neurochem 71: 288-294.
76. Murray MM, Bernstein SL, Nyugen V, Condron MM, Teplow DB, Bowers MT,. 2009. Amyloid beta protein: A beta 40 inhibits a beta 42 oligomerization. J Am Chem Soc 131: 6316-6317.
77. Nesatyy VJ,. 2002. Mass spectrometry evaluation of the solution and gas-phase binding properties of noncovalent protein complexes. Int J Mass Spectrom 221: 147-161.
78. Ouyang Z, Takats Z, Blake TA, Gologan B, Guymon AJ, Wiseman JM, Oliver JC, Davisson VJ, Cooks RG,. 2003. Preparing protein microarrays by soft-landing of mass-selected ions. Science 301: 1351-1354.
79. Politis A, Park AY, Hyung S-J, Barsky D, Ruotolo BT, Robinson CV,. 2010. Integrating ion mobility mass spectrometry with molecular modelling to determine the architecture of multiprotein complexes. PLoS ONE 5: e12080.
80. Prapunpoj P, Leelawatwattana L,. 2009. Evolutionary changes to transthyretin: Structure-function relationships. FEBS J 276: 5330-5341.
81. Pringle SD, Giles K, Wildgoose JL, Williams JP, Slade SE, Thalassinos K, Bateman RH, Bowers MT, Scrivens JH,. 2007. An investigation of the mobility separation of some peptide and protein ions using a new hybrid quadrupole/travelling wave ims/oa-tof instrument. Int J Mass Spectrom 261: 1-12.
82. Prusiner SB,. 1998. Prions. Proc Natl Acad Sci USA 95: 13363-13383.
83. Prusiner SB, Bolton DC, Groth DF, Bowman KA, Cochran SP, McKinley MP,. 1982. Further purification and characterization of scrapie prions. Biochemistry 21: 6942-6950.
84. Pukala TL,. 2011. Mass spectrometry for structural biology: Determining the composition and architecture of protein complexes. Aust J Chem 64: 681-691.
85. Pukala TL, Ruotolo BT, Zhou M, Politis A, Stefanescu R, Leary JA, Robinson CV,. 2009. Subunit architecture of multiprotein assemblies determined using restraints from gas-phase measurements. Structure 17: 1235-1243.
86. Purves R, Guevremont R, Day S, Pipich C, Matyjaszczyk M,. 1998. Mass spectrometric characterization of a high-field asymmetric waveform ion mobility spectrometer. Rev Sci Instrum 69: 4094-4105.
87. Roussel BD, Irving JA, Ekeowa UI, Belorgey D, Haq I, Ordonez A, Kruppa AJ, Duvoix A, Rashid ST, Crowther DC, Marciniak SJ, Lomas DA,. 2011. Unravelling the twists and turns of the serpinopathies. FEBS J 278: 3859-3867.
88. Ruotolo BT, Giles K, Campuzano I, Sandercock AM, Bateman RH, Robinson CV,. 2005. Evidence for macromolecular protein rings in the absence of bulk water. Science 310: 1658-1661.
89. Ruotolo BT, Benesch JLP, Sandercock AM, Hyung SJ, Robinson CV,. 2008. Ion mobility-mass spectrometry analysis of large protein complexes. Nat Protoc 3: 1139-1152.
90. Salbo R, Bush MF, Naver H, Campuzano I, Robinson CV, Pettersson I, Jorgensen TJ, Haselmann KF,. 2012. Traveling-wave ion mobility mass spectrometry of protein complexes: Accurate calibrated collision cross-sections of human insulin oligomers. Rapid Commun Mass Spectrom 26: 1181-1193.
91. Scarff CA, Thalassinos K, Hilton GR, Scrivens JH,. 2008. Travelling wave ion mobility mass spectrometry studies of protein structure: Biological significance and comparison with x-ray crystallography and nuclear magnetic resonance spectroscopy measurements. Rapid Commun Mass Spectrom 22: 3297-3304.
92. Serpell LC, Sunde M, Benson MD, Tennent GA, Pepys MB, Fraser PE,. 2000. The protofilament substructure of amyloid fibrils. J Mol Biol 300: 1033-1039.
93. Sharon M, Robinson CV,. 2007. The role of mass spectrometry in structure elucidation of dynamic protein complexes. Annu Rev Biochem 76: 167-193.
94. Shvartsburg AA, Jarrold MF,. 1996. An exact hard-spheres scattering model for the mobilities of polyatomic ions. Chem Phys Lett 261: 86-91.
95. Shvartsburg AA, Smith RD,. 2008. Fundamentals of traveling wave ion mobility spectrometry. Anal Chem 80: 9689-9699.
96. Smith DP, Giles K, Bateman RH, Radford SE, Ashcroft AE,. 2007. Monitoring copopulated conformational states during protein folding events using electrospray ionization-ion mobility spectrometry-mass spectrometry. J Am Soc Mass Spectrom 18: 2180-2190.
97. Smith DP, Radford SE, Ashcroft AE,. 2010. Elongated oligomers in beta2-microglobulin amyloid assembly revealed by ion mobility spectrometry-mass spectrometry. Proc Natl Acad Sci USA 107: 6794-6798.
98. Synowsky SA, van den Heuvel RH, Mohammed S, Pijnappel PW, Heck AJ,. 2006. Probing genuine strong interactions and post-translational modifications in the heterogeneous yeast exosome protein complex. Mol Cell Proteomics 5: 1581-1592.
99. Takats Z, Wiseman JM, Gologan B, Cooks RG,. 2004. Electrosonic spray ionization. A gentle technique for generating folded proteins and protein complexes in the gas phase and for studying ion-molecule reactions at atmospheric pressure. Anal Chem 76: 4050-4058.
100. Tanaka K, Waki H, Ido Y, Akita S, Yoshida Y, Yoshida T, Matsuo T,. 1988. Protein and polymer analyses up to m/z 100 000 by laser ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2: 151-153.
101. Thalassinos K, Grabenauer M, Slade SE, Hilton GR, Bowers MT, Scrivens JH,. 2008. Characterization of phosphorylated peptides using traveling wave-based and drift cell ion mobility mass spectrometry. Anal Chem 81: 248-254.
102. Uetrecht C, Versluis C, Watts NR, Wingfield PT, Steven AC, Heck AJR,. 2008. Stability and shape of hepatitis b virus capsids in vacuo. Angew Chem Int Ed 47: 6247-6251.
103. Uetrecht C, Rose RJ, van Duijn E, Lorenzen K, Heck AJR,. 2010. Ion mobility mass spectrometry of proteins and protein assemblies. Chem Soc Rev 39: 1633-1655.
104. Uversky VN, Li J, Fink AL,. 2001. Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J Biol Chem 276: 10737-10744.
105. Valentine SJ, Clemmer DE,. 1997. H/D exchange levels of shape-resolved cytochrome c conformers in the gas phase. J Am Chem Soc 119: 3558-3566.
106. van Duijn E,. 2010. Current limitations in native mass spectrometry based structural biology. J Am Soc Mass Spectrom 21: 971-978.
107. van Duijn E, Simmons DA, van den Heuvel RHH, Bakkes PJ, van Heerikhuizen H, Heeren RMA, Robinson CV, van der Vies SM, Heck AJR,. 2006. Tandem mass spectrometry of intact groel-substrate complexes reveals substrate-specific conformational changes in the trans ring. J Am Chem Soc 128: 4694-4702.
108. van Duijn E, Barendregt A, Synowsky S, Versluis C, Heck AJR,. 2009. Chaperonin complexes monitored by ion mobility mass spectrometry. J Am Chem Soc 131: 1452-1459.
109. Vlad C, Lindner K, Karreman C, Schildknecht S, Leist M, Tomczyk N, Rontree J, Langridge J, Danzer K, Ciossek T, Petre A, Gross ML, Hengerer B, Przybylski M,. 2011. Autoproteolytic fragments are intermediates in the oligomerization/aggregation of the Parkinson's disease protein alpha-synuclein as revealed by ion mobility mass spectrometry. ChemBioChem 12: 2740-2744.
110. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ,. 2002. Naturally secreted oligomers of amyloid [beta] protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416: 535-539.
111. Wang W, Nema S, Teagarden D,. 2010. Protein aggregation-Pathways and influencing factors. Int J Pharm 390: 89-99.
112. Watson JT, Sparkman OD,. 2007. Introduction to mass spectrometry. Instrumentation, applications and strategies for data interpretation. Chichester: John Wiley & Sons.
113. Waxman EA, Giasson BI,. 2009. Molecular mechanisms of α-synuclein neurodegeneration. Biochim Biophys Acta 1792: 616-624.
114. Wilm M, Mann M,. 1996. Analytical properties of the nanoelectrospray ion source. Anal Chem 68: 1-8.
115. Wood SJ, Wetzel R, Martin JD, Hurle MR,. 1995. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide. Biochemistry 34: 724-730.
116. Woods LA, Platt GW, Hellewell AL, Hewitt EW, Homans SW, Ashcroft AE, Radford SE,. 2011. Ligand binding to distinct states diverts aggregation of an amyloid-forming protein. Nat Chem Biol 7: 730-739.
117. Wyttenbach T, vonHelden G, Batka JJ, Carlat D, Bowers MT,. 1997. Effect of the long-range potential on ion mobility measurements. J Am Soc Mass Spectrom 8: 275-282.
118. Wyttenbach T, Kemper PR, Bowers MT,. 2001. Design of a new electrospray ion mobility mass spectrometer. Int J Mass Spectrom 212: 13-23.
119. Wyttenbach T, Grabenauer M, Thalassinos K, Scrivens JH, Bowers MT,. 2010. The effect of calcium ions and peptide ligands on the relative stabilities of the calmodulin dumbbell and compact structures. J Phys Chem B 114: 437-447.
120. Yamasaki M, Li W, Johnson DJD, Huntington JA,. 2008. Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization. Nature 455: 1255-1258.
121. Yan Y, Wang C,. 2007. Aβ40 protects non-toxic aβ42 monomer from aggregation. J Mol Biol 369: 909-916.
122. Yu L, Edalji R, Harlan JE, Holzman TF, Lopez AP, Labkovsky B, Hillen H, Barghorn S, Ebert U, Richardson PL, Miesbauer L, Solomon L, Bartley D, Walter K, Johnson RW, Hajduk PJ, Olejniczak ET,. 2009. Structural characterization of a soluble amyloid beta-peptide oligomer. Biochemistry 48: 1870-1877.
123. Zhang Y-W, Thompson R, Zhang H, Xu H,. 2011. APP processing in Alzheimer's disease. Mol Brain 4: 3.
124. Zheng X, Gessel MM, Wisniewski ML, Viswanathan K, Wright DL, Bahr BA, Bowers MT,. 2012. Z-Phe-Ala-diazomethylketone (PADK) disrupts and remodels early oligomer states of the Alzheimer disease abeta42 protein. J Biol Chem 287: 6084-6088.
125. Zolotov, Yu A,. 2006. Ion Mobility Spectrometry. Journal of Analytical Chemistry 61 (6): 519.